Luspatercept (ACE-536)
Sponsors
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Conditions
Thalassemia Major
Unknown Phase
To Evaluate Long- Term Safety and Efficacy of Luspatercept
Active, not recruitingNCT06875219
Start: 2023-04-30End: 2026-02-24Updated: 2025-03-13
Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase
Active, not recruitingNCT06913634
Start: 2023-05-30End: 2026-06-30Target: 140Updated: 2025-04-06